A detailed history of Albion Financial Group transactions in Boston Scientific Corp stock. As of the latest transaction made, Albion Financial Group holds 645 shares of BSX stock, worth $49,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
645
Previous 535 20.56%
Holding current value
$49,278
Previous $30,000 46.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$57.6 - $68.62 $6,336 - $7,548
110 Added 20.56%
645 $44,000
Q3 2022

Oct 27, 2022

SELL
$36.71 - $109.66 $2,239 - $6,689
-61 Reduced 10.23%
535 $21,000
Q1 2022

May 09, 2022

SELL
$40.9 - $45.1 $2,494 - $2,751
-61 Reduced 9.28%
596 $26,000
Q4 2021

Feb 15, 2022

SELL
$38.07 - $44.87 $1,027 - $1,211
-27 Reduced 3.95%
657 $28,000
Q4 2020

Feb 19, 2021

BUY
$33.15 - $41.97 $22,674 - $28,707
684 New
684 $25,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.